<DOC>
	<DOCNO>NCT02625844</DOCNO>
	<brief_summary>This study document time spend health care personnel anemia-related task , include preparation , distribution administration monopegylated epoetin beta ( Mircera ) erythropoiesis-stimulating agent ( ESAs ) patient end stage renal disease hemodialysis center Croatia . The total average time determined number patient monopegylated epoetin beta patient ESAs . In addition , qualitative information obtain change practice pattern may occur introduction monopegylated epoetin beta .</brief_summary>
	<brief_title>Health Care Personnel Time Anemia Management With Erythropoiesis Stimulating Agents Hemodialysis Centers Croatia</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Hematinics</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>Treatment symptomatic anemia associate chronic kidney disease ( CKD ) adult patient Hypersensitivity active substance excipients Uncontrolled hypertension</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>